Watchlist Price Alert

TCR2 Therapeutics Inc. (TCRR)

NASDAQ: TCRR · Real-Time Price · USD

1.48

0.00 (0.00%)

At close: May 31, 2023, 8:00 PM

TCR2 Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-151.82M	-99.81M	-67.12M	-47.6M	-24.25M	-13.07M	-9.91M
Depreciation & Amortization	3.05M	2.83M	1.59M	862K	419K	298K	220K
Stock-Based Compensation	11.38M	12.27M	8.49M	6.7M	2.13M	408K	93K
Other Working Capital	8.41M	2.39M	421K	-920K	975K	430K	146K
Other Non-Cash Items	26.65M	1.4M	-702K	-225K	-278K	-1K	n/a
Deferred Income Tax	-293K	99K	131K	n/a	n/a	n/a	n/a
Change in Working Capital	9.58M	1.62M	872K	-1.1M	3.2M	329K	222K
Operating Cash Flow	-101.46M	-81.6M	-56.74M	-41.36M	-18.78M	-12.04M	-9.38M
Capital Expenditures	-15.45M	-11.45M	-7.16M	-3.88M	-1.02M	-388K	-869K
Cash Acquisitions	15.45M	351K	7.78M	4.15M	1.03M	n/a	n/a
Purchase of Investments	-267.52M	-50.73M	-152.81M	-126.26M	-97.81M	-6.48M	-8.35M
Sales Maturities Of Investments	194.49M	140.62M	111.04M	109.72M	22.49M	14.83M	n/a
Other Investing Acitivies	-15.45M	-351K	-7.78M	-4.15M	-1.03M	-290K	n/a
Investing Cash Flow	-88.49M	78.45M	-48.94M	-20.41M	-76.34M	7.67M	-9.22M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	125K	132.14M	134.7M	79.52M	122.98M	16.18M	22.49M
Financial Cash Flow	125K	132.14M	134.7M	79.52M	122.98M	16.18M	22.49M
Net Cash Flow	-189.82M	128.98M	29.02M	17.75M	27.86M	11.82M	3.89M
Free Cash Flow	-116.91M	-93.05M	-63.9M	-45.24M	-19.8M	-12.42M	-10.25M